These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process. Lin M, Stoica-Nazarov C, Surls J, Kehl M, Bona C, Olsen C, Brumeanu TD, Casares S. Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111 [Abstract] [Full Text] [Related]
5. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant. Kanagawa O, Vaupel BA, Xu G, Unanue ER, Katz JD. J Immunol; 1998 Nov 01; 161(9):4489-92. PubMed ID: 9794372 [Abstract] [Full Text] [Related]
10. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice. Casares S, Lin M, Zhang N, Teijaro JR, Stoica C, McEvoy R, Farber DL, Bona C, Brumeanu TD. Transplantation; 2008 Jun 27; 85(12):1717-25. PubMed ID: 18580462 [Abstract] [Full Text] [Related]
13. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction. Liu QS, Zhang RH, Chu YW, Xiong SD. Sheng Li Xue Bao; 2003 Dec 25; 55(6):633-40. PubMed ID: 14695478 [Abstract] [Full Text] [Related]
14. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity. Zhao Y, Rodriguez-Barbosa JI, Shimizu A, Sachs DH, Sykes M. Transplantation; 2003 Jun 15; 75(11):1832-40. PubMed ID: 12811242 [Abstract] [Full Text] [Related]
16. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Gregerson DS, Heuss ND, Lew KL, McPherson SW, Ferrington DA. Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4654-63. PubMed ID: 17898289 [Abstract] [Full Text] [Related]
17. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera. Casares S, Stan AC, Bona CA, Brumeanu TD. Nat Biotechnol; 2001 Feb 15; 19(2):142-7. PubMed ID: 11175728 [Abstract] [Full Text] [Related]
18. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide. Wu AY, Schulman SJ, Marconi LA, Reilly CR, Scott B, Lo D. Cell Immunol; 1998 Mar 15; 184(2):112-20. PubMed ID: 9630837 [Abstract] [Full Text] [Related]
19. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes. Preda I, McEvoy RC, Lin M, Bona CA, Rapaport R, Brumeanu TD, Casares S. Eur J Immunol; 2005 Sep 15; 35(9):2762-75. PubMed ID: 16106371 [Abstract] [Full Text] [Related]
20. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM. Diabetes; 2006 Jul 15; 55(7):2098-105. PubMed ID: 16804081 [Abstract] [Full Text] [Related] Page: [Next] [New Search]